InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Pet Vaccine Market– (Animal Type (Canine, Feline and Equine), By Mode of Administration (Injectable, Intranasal, and Others)), By Vaccine Type, By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2034.”
According to the latest research by InsightAce Analytic, the Global Pet Vaccine Market is valued at USD 11.7 Bn in 2024, and it is expected to reach USD 23.1 Bn by 2034, with a CAGR of 7.4 % during the forecast period of 2025-2034.
Check this Report Brochure : https://www.insightaceanalytic.com/request-sample/2981
Pet vaccines are biological preparations designed to stimulate the immune system of animals, providing protection against infectious diseases and reducing the transmission of pathogens among animal populations. These vaccines also play a critical role in preventing zoonotic diseases, thereby safeguarding public health by enhancing overall animal well-being. The global demand for pet vaccines is being driven by increasing pet ownership and heightened awareness regarding animal health. Specifically, the rising need for vaccinations among companion animals, such as dogs and cats, is a key market growth factor. This trend is further supported by government initiatives promoting livestock vaccination programs and stringent regulatory mandates requiring mandatory vaccinations. Additionally, expanded animal health insurance coverage, which frequently includes vaccination costs, encourages pet owners to invest in preventive healthcare measures. The growing perception of pets as integral family members, combined with increasing disposable income levels, also contributes significantly to the expanding demand for pet vaccines worldwide.
List of Prominent Players in the Pet Vaccine Market:
- Bayer AG
- Elanco US Inc.
- Merck KGaA
- Merial Inc.
- Virbac SA
- Zoetis Inc
- Phibro Animal Health Corporation
- Boehringer Ingelheim GmbH
- Tianjin Ringpu Bio-Technology Co., Ltd
- Vetoquinol SA
- Others
Market Dynamics
Drivers:
The pet vaccine market is experiencing robust growth driven by the increasing prevalence of infectious diseases, including zoonotic illnesses transmissible between animals and humans. Vaccinations play a critical role in preventing common conditions such as distemper, pneumonia, parvovirus, and feline leukemia. Advances in genetic engineering and biotechnology have facilitated the development of innovative vaccines that provide broader protection against a range of diseases. Additionally, heightened awareness among pet owners regarding the importance of immunization for disease prevention and the extension of pet lifespan is a significant factor propelling market expansion.
Challenges:
One of the primary challenges facing the pet vaccine market is the high cost of vaccination, which can limit access to essential preventive care, particularly in low-income regions. Vaccine prices vary based on factors such as manufacturer, vaccine type, and geographic location. Costs associated with research and development, manufacturing, transportation, and regulatory compliance contribute to pricing. Furthermore, veterinary consultation fees add to the overall expense, potentially restricting vaccine uptake. These financial barriers, especially in economically disadvantaged areas, may impede market growth.
Regional Trends:
North America is expected to maintain a dominant share of the pet vaccine market and exhibit strong compound annual growth, driven by substantial investment in scientific research and technological innovation in pet immunization. The region benefits from a favorable regulatory environment and continuous advancements in vaccine safety and efficacy. Europe also holds a significant market share, supported by stringent regulations protecting animal health and welfare, well-established pharmaceutical companies, and growing demand for preventive healthcare products. Government initiatives and regulatory frameworks aimed at controlling zoonotic diseases are anticipated to further stimulate demand for pet vaccines across the region.
Recent Developments:
- In September 2024, Bayer declared its firm had secured a unique permit for an innovative biology pesticide by signing a deal with AlphaBio Command, a UK-based company. The newly developed good is expected to be the initial for crops, such as grains and oilseed rape, to be made affordable. This new pesticide was found by AlphaBio, for which Bayer distributes FLiPPER, a successful bioinsecticide-acaricide. Its initial launch is scheduled to take place, assuming further investigation and authorization.
- In October 2024, Merck and Gilead Sciences, Inc. revealed the findings of the second section of the research program assessing a mixture of lenacapavir, a first-in-class HIV-1 infection capstone preventive and islatravir, an investigational amino acid transcription migration drug.
Segmentation of Pet Vaccine Market-
Pet Vaccine Market-By Animal Type
- Canine
- Feline
- Equine
Pet Vaccine Market-By Vaccine Type
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
Pet Vaccine Market-By Mode of Administration
- Injectable Vaccines
- Intranasal Vaccines
- Others
Pet Vaccine Market-By Region
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
